FDA Ups ARIA Monitoring for Aduhelm; Doubles MRI Requirement
UPDATE: 3 March 2024, 8:30 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
UPDATE: 3 March 2024, 8:30 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
A new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia (PPA) have Alzheimer’s-like plaques and tangles in their brains…
Remember what happened the last time you sat down to finish your taxes — a task which is both necessary and boring? First, you…
Imagine the brain as a sprawling art exhibit: Several large marble and clay statues are visible as far as the eye can see —…
The lack of effective treatments for Alzheimer’s have spurred scientists to rethink the dominant approach to tackling the disease: the amyloid hypothesis. This hypothesis…
In the 1990s, the idea that clumps of beta-amyloid proteins are the main culprits of Alzheimer’s took off, and this line of thought —…
The FDA’s approval of Biogen’s new anti-amyloid drug Aduhelm was a landmark moment for Alzheimer’s — and it comes with no small amount of…
“Historic moment:” Today, the FDA gave Biogen’s investigational Alzheimer’s drug aducanumab its approval, with the requirement that they conduct a post-approval trial. UPDATE: 3…
With the right signals, non-differentiated human cells called stem cells have the potential to divide and multiply into all different types of cells. Due…
This weekend, Eli Lilly and Company presented detailed results of its phase 2 TRAILBLAZER-ALZ trial, showing that its investigational drug donanemab — monoclonal antibody…
The Alzheimer’s research community has been working for decades to find an effective treatment for Alzheimer’s disease, largely by targeting one of the hallmarks…
The initial results from Eli Lilly and Co’s Phase 2 clinical trial for experimental Alzheimer’s drug donanemab provide much needed hope for the Alzheimer’s…
“Can I look into your future and can I accurately estimate how much beta-amyloid you’re going to accumulate over the next two years, the…
The idea that a common viral or bacterial infection could lead, decades later, to the onset of Alzheimer’s was proposed over 30 years ago….
As scientists search for ways to prevent Alzheimer’s, a team of researchers in Switzerland and Italy confirm the link between an imbalance in gut…